Tissue-engineered skeletal muscle holds promise as a source of graft tissue for repair of volumetric muscle loss and as a model system for pharmaceutical testing. To reach this potential, engineered tissues must advance past the neonatal phenotype that characterizes the current state of the art. In this review, we describe native skeletal muscle development and identify important growth factors controlling this process. By comparing in vivo myogenesis to in vitro satellite cell cultures and tissue engineering approaches, several key similarities and differences that may potentially advance tissue-engineered skeletal muscle were identified. In particular, hepatocyte and fibroblast growth factors used to accelerate satellite cell activation and proliferation, followed by addition of insulin-like growth factor as a potent inducer of differentiation, are proven methods for increased myogenesis in engineered muscle. Additionally, we review our recent novel application of dexamethasone (DEX), a glucocorticoid that stimulates myoblast differentiation, in skeletal muscle tissue engineering. Using our established skeletal muscle unit (SMU) fabrication protocol, timing- and dose-dependent effects of DEX were measured. The supplemented SMUs demonstrated advanced sarcomeric structure and significantly increased myotube diameter and myotube fusion compared to untreated controls. Most significantly, these SMUs exhibited a fivefold rise in force production. Thus, we concluded that DEX may serve to improve myogenesis, advance muscle structure, and increase force production in engineered skeletal muscle.

1.
Allen, R.E., L.K. Boxhorn (1989) Regulation of skeletal muscle satellite cell proliferation and differentiation by transforming growth factor-beta, insulin-like growth factor I, and fibroblast growth factor. J Cell Physiol 138: 311-315.
2.
Allen, R.E., S.M. Sheehan, R.G. Taylor, T.L. Kendall, G.M. Rice (1995) Hepatocyte growth factor activates quiescent skeletal muscle satellite cells in vitro. J Cell Physiol 165: 307-312.
3.
Allen, R.E., C.J. Temm-Grove, S.M. Sheehan, G. Rice (1997) Skeletal muscle satellite cell cultures. Methods Cell Biol 52: 155-176.
4.
Bach, A.D., J. Stern-Straeter, J.P. Beier, H. Bannasch, G.B. Stark (2003) Engineering of muscle tissue. Clin Plast Surg 30: 589-599.
5.
Belanto, J.J., S.V. Diaz-Perez, C.E. Magyar, M.M. Maxwell, Y. Yilmaz, K. Topp, G. Boso, C.H. Jamieson, C.A.M. Jamieson, N.A. Cacalano (2010) Dexamethasone induces dysferlin in myoblasts and enhances their myogenic differentiation. Neuromuscul Disord 20: 111-121.
6.
Bentzinger, C.F., Y.X. Wang, M.A. Rudnicki (2012) Building muscle: molecular regulation of myogenesis. Cold Spring Harb Perspect Biol 4: a008342.
7.
Biressi, S., M. Molinaro, G. Cossu (2007) Cellular heterogeneity during vertebrate skeletal muscle development. Dev Biol 308: 281-293.
8.
Buckingham, M., A. Mayeuf (2012) Skeletal muscle development; in Olson, J.A.H.N. (ed): Muscle. Boston/Waltham, Academic Press, chapt 52, pp 749-762.
9.
Carosio, S., L. Barberi, E. Rizzuto, C. Nicoletti, Z. Del Prete, A. Musarò (2013) Generation of eX vivo-vascularized muscle engineered tissue (X-MET). Sci Rep 3: 1420-1429.
10.
Chakravarthy, M.V., T.W. Abraha, R.J. Schwartz, M.L. Fiorotto, F.W. Booth (2000) Insulin-like growth factor-I extends in vitro replicative life span of skeletal muscle satellite cells by enhancing G1/S cell cycle progression via the activation of phosphatidylinositol 3′-kinase/Akt signaling pathway. J Biol Chem 275: 35942-35952.
11.
Clegg, C.H., T.A. Linkhart, B.B. Olwin, S.D. Hauschka (1987) Growth factor control of skeletal muscle differentiation: commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor. J Cell Biol 105: 949-956.
12.
Corona, B.T., C.L. Ward, H.B. Baker, T.J. Walters, G.J. Christ (2014) Implantation of in vitro tissue engineered muscle repair constructs and bladder acellular matrices partially restore in vivo skeletal muscle function in a rat model of volumetric muscle loss injury. Tissue Eng Part A 20: 705-715.
13.
Cosgrove, B.D., A. Sacco, P.M. Gilbert, H.M. Blau (2009) A home away from home: challenges and opportunities in engineering in vitro muscle satellite cell niches. Differentiation 78: 185-194.
14.
Dammeier, J., H.D. Beer, M. Brauchle, S. Werner (1998) Dexamethasone is a novel potent inducer of connective tissue growth factor expression - implications for glucocorticoid therapy. J Biol Chem 273: 18185-18190.
15.
Dennis, R.G., B. Smith, A. Philp, K. Donnelly, K. Baar (2009) Bioreactors for guiding muscle tissue growth and development. Adv Biochem Engin Biotechnol 112: 39-79.
16.
Desler, M.M., S.J. Jones, C.W. Smith, T.L. Woods (1996) Effects of dexamethasone and anabolic agents on proliferation and protein synthesis and degradation in C2C12 myogenic cells. J Anim Sci 74: 1265-1273.
17.
Dhawan, J., T.A. Rando (2005) Stem cells in postnatal myogenesis: molecular mechanisms of satellite cell quiescence, activation and replenishment. Trends Cell Biol 15: 666-673.
18.
Doumit, M.E., R.A. Merkel (1992) Conditions for isolation and culture of porcine myogenic satellite cells. Tissue Cell 24: 253-262.
19.
Düsterhöft, S., D. Pette (1999) Evidence that acidic fibroblast growth factor promotes maturation of rat satellite-cell-derived myotubes in vitro. Differentiation 65: 161-169.
20.
Glass, D.J. (2003) Signalling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat Cell Biol 5: 87-90.
21.
Glass, D.J. (2005) Skeletal muscle hypertrophy and atrophy signaling pathways. Int J Biochem Cell Biol 37: 1974-1984.
22.
Grefte, S., A.M. Kuijpers-Jagtman, R. Torensma, J.W.V.d. Hoff (2007) Skeletal muscle development and regeneration. Stem Cells Dev 16: 857-868.
23.
Gumucio, J. P., C.L. Mendias (2013) Atrogin-1, MuRF-1, and sarcopenia. Endocrine 43: 12-21.
24.
Huang, Y., R.G. Dennis, L.M. Larkin, K. Baar (2004) Rapid formation of functional muscle in vitro using fibrin gels. J Appl Physiol 98: 706-713.
25.
Huard, J., Y. Li, F.H. Fu (2002) Muscle injuries and repair: current trends in research. J Bone Joint Surg 84-A: 822-832.
26.
Husmann, I., L. Soulet, J. Gautron, I. Martelly, D. Barritault (1996) Growth factors in skeletal muscle regeneration. Cytokine Growth Factor Rev 7: 249-258.
27.
Inder, W.J., C. Jang, V.R. Obeyesekere, F.P. Alford (2010) Dexamethasone administration inhibits skeletal muscle expression of the androgen receptor and IGF-1 - implications for steroid-induced myopathy. Clin Endocrinol (Oxf) 73: 126-132.
28.
Jackman, R.W., S.C. Kandarian (2004) The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol 287: 834-843.
29.
Juhas, M., G.C. Engelmayr, A.N. Fontanella, G.M. Palmer, N. Bursac (2014) Biomimetic engineered muscle with capacity for vascular integration and functional maturation in vivo. Proc Natl Acad Sci USA 111: 5508-5513.
30.
Khodabukus, A., K. Baar (2014) The effect of serum origin on tissue engineered skeletal muscle function. J Cell Biochem 115: 2198.
31.
Khodabukus, A., K. Baar (2015) Glucose concentration and streptomycin alter in vitro muscle function and metabolism. J Cell Physiol 230: 1226.
32.
Koning, M., M.C. Harmsen, M.J.A. van Luyn, P.M.N. Werker (2009) Current opportunities and challenges in skeletal muscle tissue engineering. J Tissue Eng Regen Med 3: 407-415.
33.
Kuang, S., M.A. Gillespie, M.A. Rudnicki (2008) Niche regulation of muscle satellite cell self-renewal and differentiation. Cell Stem Cell 2: 22-31.
34.
Lam, M.T., Y. Huang, R.K. Birla, S. Takayama (2009) Microfeature guided skeletal muscle tissue engineering for highly organized 3-dimensional free-standing constructs. Biomaterials 30: 1150-1155.
35.
Lee, P.H.U., H.H. Vandenburgh (2013) Skeletal muscle atrophy in bioengineered skeletal muscle: a new model system. Tissue Eng Part A 19: 2147-2155.
36.
Maley, M.A.L., M.J. Davies, M.D. Grounds (1995) Extracellular matrix, growth factors, genetics: their influence on cell proliferation and myotube formation in primary cultures of adult mouse skeletal muscle. Exp Cell Res 219: 169-179.
37.
Martin, N.R.W., S.L. Passey, D.J. Player, A. Khodabukus, R.A. Ferguson, A.P. Sharples, V. Mudera, K. Baar, M.P. Lewis (2013) Factors affecting the structure and maturation of human tissue engineered skeletal muscle. Biomaterials 34: 5759-5765.
38.
Mathew, S.J., J.M. Hansen, A.J. Merrell, M.M. Murphy, J.A. Lawson, D.A. Hutcheson, M.S. Hansen, M. Angus-Hill, G. Kardon (2011) Connective tissue fibroblasts and Tcf4 regulate myogenesis. Development 138: 371-384.
39.
Mauro, A. (1961) Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 9: 493-495.
40.
McFarland, D.C., J.E. Pesall, C.S. Coy, S.G. Velleman (2013) Effects of 17ß-estradiol on turkey myogenic satellite cell proliferation, differentiation, and expression of glypican-1, MyoD and myogenin. Comp Biochem Physiol A Mol Integr Physiol 164: 565-571.
41.
Murphy, M.M., J.A. Lawson, S.J. Mathew, D.A. Hutcheson, G. Kardon (2011) Satellite cells, connective tissue fibroblasts and their interactions are crucial for muscle regeneration. Development 138: 3625-3637.
42.
Neal, D., M.S. Sakar, L.S. Ong, H.H. Asada (2014) Formation of elongated fascicle-inspired 3D tissues consisting of high-density, aligned cells using sacrificial outer molding. Lab Chip 14: 1907-1916.
43.
Qin, J., R. Du, Y. Yang, H. Zhang, Q. Li, L. Liu, H. Guan, J. Hou, X. An (2013) Dexamethasone-induced skeletal muscle atrophy was associated with upregulation of myostatin promoter activity. Res Vet Sci 94: 84-89.
44.
Sakar, M.S., D. Neal, T. Boudou, M.A. Borochin, Y. Li, R. Weiss, R.D. Kamm, C.S. Chen, H.H. Asada (2012) Formation and optogenetic control of engineered 3D skeletal muscle bioactuators. Lab Chip 12: 4976.
45.
Sandri, M. (2008) Signaling in muscle atrophy and hypertrophy. Physiology 23: 160-170.
46.
Schiaffino, S., C. Mammucari (2011) Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models. Skelet Muscle 1: 4.
47.
Sicari, B.M., J.P. Rubin, C.L. Dearth, M.T. Wolf, F. Ambrosio, M. Boninger, N.J. Turner, D.J. Weber, T.W. Simpson, A. Wyse, E.H.P. Brown, J.L. Dziki, L.E. Fisher, S. Brown, S.F. Badylak (2014) An acellular biologic scaffold promotes skeletal muscle formation in mice and humans with volumetric muscle loss. Sci Transl Med 6: 234ra58.
48.
Syverud, B., K. VanDusen, L. Larkin (2016) Effects of dexamethasone on satellite cells and tissue engineered skeletal muscle units. Tissue Eng Part A 22: 480-489.
49.
VanDusen, K.W., B.C. Syverud, M.L. Williams, J.D. Lee, L.M. Larkin (2014) Engineered skeletal muscle units for repair of volumetric muscle loss in the tibialis anterior muscle of a rat. Tissue Eng Part A 20: 2920-2930.
50.
Wagers, A.J., I.M. Conboy (2005) Cellular and molecular signatures of muscle regeneration: current concepts and controversies in adult myogenesis. Cell 122: 659-667.
51.
Wang, B., Z. Yang, B.K. Brisson, H. Feng, Z. Zhang, E.M. Welch, S.W. Peltz, E.R. Barton, R.H. Brown, Jr., H.L. Sweeney (2010) Membrane blebbing as an assessment of functional rescue of dysferlin-deficient human myotubes via nonsense suppression. J Appl Physiol 109: 901-905.
52.
Weist, M.R., M.S. Wellington, J.E. Bermudez, T.Y. Kostrominova, C.L. Mendias, E.M. Arruda, L.M. Larkin (2013) TGFβ1 enhances contractility in engineered skeletal muscle. J Tissue Eng Regen Med 7: 562-571.
53.
Williams, M.L., T.Y. Kostrominova, E.M. Arruda, L.M. Larkin (2013) Effect of implantation on engineered skeletal muscle constructs. J Tissue Eng Regen Med 7: 434-442.
54.
Wu, X., B.T. Corona, X. Chen, T.J. Walters (2012) A standardized rat model of volumetric muscle loss injury for the development of tissue engineering therapies. BioRes Open Access 1: 280-290.
55.
Yablonka-Reuveni, Z., T.M. Balestreri, D.F. Bowen-Pope (1990) Regulation of proliferation and differentiation of myoblasts derived from adult mouse skeletal muscle by specific isoforms of PDGF. J Cell Biol 111: 1623-1629.
56.
Yin, H., F. Price, M.A. Rudnicki (2013) Satellite cells and the muscle stem cell niche. Physiol Rev 93: 23-67.
57.
Zanou, N., P. Gailly (2013) Skeletal muscle hypertrophy and regeneration: interplay between the myogenic regulatory factors (MRFs) and insulin-like growth factors (IGFs) pathways. Cell Mol Life Sci 70: 4117.
58.
Zhang, P., X. Liang, T. Shan, Q. Jiang, C. Deng, R. Zheng, S. Kuang (2015) mTOR is necessary for proper satellite cell activity and skeletal muscle regeneration. Biochem Biophys Res Commun 463: 102.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.